PMID: 9185696Jun 11, 1997Paper

Breast implants and cancer risk in Denmark

International Journal of Cancer. Journal International Du Cancer
S FriisJ H Olsen

Abstract

Although millions of women worldwide have received breast implants for cosmetic or medical reasons, possible late effects (in particular cancer) have not been well studied. To provide quantitative information on cancer occurrence among women undergoing breast implant surgery, 1,135 women treated for cosmetic reasons in Denmark were evaluated. Patients were identified using the nationwide Hospital Discharge Registry with linkage to the nationwide Danish Cancer Registry to determine subsequent cancer incidence. The average age of the women at implant surgery was 31 years, and the average follow-up was 8.4 years, up to a maximum of 17 years. Overall, 27 cancers developed after implant surgery compared with 24.7 expected based on incidence rates from the general population (standardized incidence ratio [SIR] = 1.1; 95% CI: 0.7-1.6). Eight breast cancers were observed vs. 7.8 expected (SIR = 1.0; 95% CI: 0.4-2.0). No evidence was found to link breast implants with increased cancer risk in the decade after surgery. While the results are encouraging, longer follow-up into later life will be necessary to assess fully any possible adverse effects.

References

May 30, 1992·Lancet·K E MaloneL F Voigt
Nov 1, 1992·Epidemiology·D Trichopoulos, R D Lipman
Apr 1, 1992·Plastic and Reconstructive Surgery·D M Deapen, G S Brody
Jan 1, 1984·Annals of Plastic Surgery·V GottliebS Pagadala
May 1, 1984·American Journal of Epidemiology·M Ewertz, O M Jensen
Sep 20, 1995·Journal of the National Cancer Institute·J K McLaughlinJ F Fraumeni
Feb 15, 1995·Journal of the National Cancer Institute·D Deapen, G Brody
Jun 8, 1995·The New England Journal of Medicine·H Bryant, P Brasher
Jun 1, 1995·Journal of the American Academy of Dermatology·M DuvicE C Vonderheid
Jul 20, 1994·Journal of the National Cancer Institute·M PotterF W Miller
Apr 1, 1994·Journal of Biomaterials Applications·K G Brand
Sep 21, 1994·Journal of the National Cancer Institute·J K McLaughlinL Mellemkjaer
Jan 1, 1993·Aesthetic Plastic Surgery·R A ErsekG Sas
Feb 1, 1996·Plastic and Reconstructive Surgery·L A BrintonJ L Stanford
Dec 1, 1996·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·M Lipkin

❮ Previous
Next ❯

Citations

Mar 3, 2010·Plastic and Reconstructive Surgery·J Peter RubinLewis H Kuller
Jul 7, 2007·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·S A McIntosh, K Horgan
Sep 10, 2005·International Journal of Cancer. Journal International Du Cancer·Søren FriisJørgen H Olsen
Sep 20, 2005·Annales de chirurgie plastique et esthétique·A MeunierE Delay
Dec 11, 2013·Clinical Breast Cancer·Jeremy C JonesHarris V Naina
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Jacques BrissonYang Mao
Nov 10, 2007·Annals of Plastic Surgery·Thomas J GampperRaymond F Morgan
Dec 27, 2007·Plastic and Reconstructive Surgery·Bruce Cunningham
Dec 27, 2007·Plastic and Reconstructive Surgery·Dennis Deapen
Dec 27, 2007·Plastic and Reconstructive Surgery·Neal Handel
Dec 27, 2007·Plastic and Reconstructive Surgery·Louise A Brinton
May 4, 2001·Plastic and Reconstructive Surgery·S J HoshawL L Perkins
Feb 1, 2003·Breast Cancer Research : BCR·Dimitrios Trichopoulos
Aug 26, 2006·Plastic and Reconstructive Surgery·Neal Handel, Melvin J Silverstein
Oct 25, 2013·Journal of breast cancer·Euddeum ShimGil Soo Son
May 5, 2001·Epidemiology·L A BrintonR N Hoover
Jan 9, 2015·Aesthetic Surgery Journal·Eline C NoelsEsther Bastiaannet
Feb 5, 1998·Journal of the National Cancer Institute·J K McLaughlinH O Adami
Jan 5, 2002·Cancer Investigation·R C Herdman, T J Fahey
Oct 27, 2004·Annals of Plastic Surgery·Ilona KulmalaRiitta Luoto
Mar 4, 2000·Plastic and Reconstructive Surgery·D DeapenG S Brody
Jun 20, 2002·Epidemiology·S Lori Brown
Apr 5, 2002·Plastic and Reconstructive Surgery·Eric David Austad
May 14, 2010·Plastic and Reconstructive Surgery·Marisa MarquesJosé Amarante
Mar 23, 2002·Leukemia & Lymphoma·Guylaine GaudetArnold S Freedman
Oct 6, 1997·Journal of the National Cancer Institute·L A Brinton, S L Brown
Aug 2, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eric LavigneJacques Brisson
Dec 14, 2012·Applied Immunohistochemistry & Molecular Morphology : AIMM·Clive R TaylorGarry S Brody

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
E WeiderpassH O Adami
© 2021 Meta ULC. All rights reserved